Literature DB >> 26041966

Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure.

Roger F Butterworth1.   

Abstract

Neuropathologic investigations in acute liver failure (ALF) reveal significant alterations to neuroglia consisting of swelling of astrocytes leading to cytotoxic brain edema and intracranial hypertension as well as activation of microglia indicative of a central neuroinflammatory response. Increased arterial ammonia concentrations in patients with ALF are predictors of patients at risk for the development of brain herniation. Molecular and spectroscopic techniques in ALF reveal alterations in expression of an array of genes coding for neuroglial proteins involved in cell volume regulation and mitochondrial function as well as in the transport of neurotransmitter amino acids and in the synthesis of pro-inflammatory cytokines. Liver-brain pro-inflammatory signaling mechanisms involving transduction of systemically-derived cytokines, ammonia neurotoxicity and exposure to increased brain lactate have been proposed. Mild hypothermia and N-Acetyl cysteine have both hepato-protective and neuro-protective properties in ALF. Potentially effective anti-inflammatory agents aimed at control of encephalopathy and brain edema in ALF include etanercept and the antibiotic minocycline, a potent inhibitor of microglial activation. Translation of these potentially-interesting findings to the clinic is anxiously awaited.

Entities:  

Keywords:  ALF, acute liver failure; ATP, adenosine triphosphate; BBB, blood-brain barrier; CCL2, chemokine ligand-2; CMRO2, cerebral metabolic rate for oxygen; CNS, central nervous system; EEG, electroencephalography; GABA, gamma-aminobutyric acid; GFAP, glial fibrillary acidic protein; IgG, immunoglobulin; MRS, magnetic resonance spectroscopy; NAC, N-Acetyl cysteine; NMDA, N-methyl-d-aspartate; SIRS, systemic inflammatory response syndrome; SNATs, several neutral amino acid transport systems; TLP, translocator protein; TNFα, tumor necrosis factor alpha; acute liver failure; hepatic encephalopathy; intracranial hypertension; microglial activation; neuroinflammation

Year:  2014        PMID: 26041966      PMCID: PMC4442857          DOI: 10.1016/j.jceh.2014.02.004

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  65 in total

1.  Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.

Authors:  A S Basile; R D Hughes; P M Harrison; Y Murata; L Pannell; E A Jones; R Williams; P Skolnick
Journal:  N Engl J Med       Date:  1991-08-15       Impact factor: 91.245

2.  Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure.

Authors:  M Kato; R D Hughes; R T Keays; R Williams
Journal:  Hepatology       Date:  1992-06       Impact factor: 17.425

3.  Effect of body temperature on brain edema and encephalopathy in the rat after hepatic devascularization.

Authors:  P Traber; M DalCanto; D Ganger; A T Blei
Journal:  Gastroenterology       Date:  1989-03       Impact factor: 22.682

4.  N-acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms.

Authors:  Chantal Bémeur; Javier Vaquero; Paul Desjardins; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2010-04-30       Impact factor: 3.584

5.  Mild hypothermia prevents brain edema and attenuates up-regulation of the astrocytic benzodiazepine receptor in experimental acute liver failure.

Authors:  Mireille Bélanger; Paul Desjardins; Nicolas Chatauret; Christopher Rose; Roger F Butterworth
Journal:  J Hepatol       Date:  2005-05       Impact factor: 25.083

6.  IL-1 or TNF receptor gene deletion delays onset of encephalopathy and attenuates brain edema in experimental acute liver failure.

Authors:  Chantal Bémeur; Hong Qu; Paul Desjardins; Roger F Butterworth
Journal:  Neurochem Int       Date:  2009-11-17       Impact factor: 3.921

7.  Acute liver failure and hyperammonemia increase peripheral-type benzodiazepine receptor binding and pregnenolone synthesis in mouse brain.

Authors:  Y Itzhak; A Roig-Cantisano; R S Dombro; M D Norenberg
Journal:  Brain Res       Date:  1995-12-24       Impact factor: 3.252

8.  Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure.

Authors:  A Michalak; C Rose; J Butterworth; R F Butterworth
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

9.  Direct evidence for central proinflammatory mechanisms in rats with experimental acute liver failure: protective effect of hypothermia.

Authors:  Wenlei Jiang; Paul Desjardins; Roger F Butterworth
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-04       Impact factor: 6.200

10.  Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications.

Authors:  Anne Chastre; Mireille Bélanger; Elizabeth Beauchesne; Bich N Nguyen; Paul Desjardins; Roger F Butterworth
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

View more
  36 in total

Review 1.  Brain edema: a valid endpoint for measuring hepatic encephalopathy?

Authors:  Chantal Bémeur; Cristina Cudalbu; Gitte Dam; Alexander S Thrane; Arthur J L Cooper; Christopher F Rose
Journal:  Metab Brain Dis       Date:  2016-06-07       Impact factor: 3.584

2.  Hepatobiliary Quiz (Answers)-14 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-06-27

3.  Gene expression profiling of brain cortex microvessels may support brain vasodilation in acute liver failure rat models.

Authors:  Lluis Palenzuela; Marc Oria; Jordi Romero-Giménez; Teresa Garcia-Lezana; Laia Chavarria; Juan Cordoba
Journal:  Metab Brain Dis       Date:  2016-07-12       Impact factor: 3.584

Review 4.  Acetaminophen from liver to brain: New insights into drug pharmacological action and toxicity.

Authors:  Carolina I Ghanem; María J Pérez; José E Manautou; Aldo D Mottino
Journal:  Pharmacol Res       Date:  2016-02-26       Impact factor: 7.658

Review 5.  Cerebral edema and liver disease: Classic perspectives and contemporary hypotheses on mechanism.

Authors:  Eric M Liotta; W Taylor Kimberly
Journal:  Neurosci Lett       Date:  2020-02-05       Impact factor: 3.046

Review 6.  The role of the gut-brain axis in alcohol use disorders.

Authors:  Jonathan Gorky; James Schwaber
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-07-16       Impact factor: 5.067

7.  Protective Roles of N-acetyl Cysteine and/or Taurine against Sumatriptan-Induced Hepatotoxicity.

Authors:  Javad Khalili Fard; Hossein Hamzeiy; Mohammadreza Sattari; Mohammad Ali Eghbal
Journal:  Adv Pharm Bull       Date:  2016-12-22

8.  Analysis of cerebral blood flow and intracranial hypertension in critical patients with non-hepatic hyperammonemia.

Authors:  Alexandre Sanches Larangeira; Marcos Toshiyuki Tanita; Marcos Antonio Dias; Olavo Franco Ferreira Filho; Vinicius Daher Alvares Delfino; Lucienne Tibery Queiroz Cardoso; Cintia Magalhães Carvalho Grion
Journal:  Metab Brain Dis       Date:  2018-05-03       Impact factor: 3.584

9.  Hepatic Encephalopathy in Children With Acute Liver Failure: Utility of Serum Neuromarkers.

Authors:  Nicole A Toney; Michael J Bell; Steven H Belle; Regina M Hardison; Norberto Rodriguez-Baez; Kathleen M Loomes; Yoram Vodovotz; Ruben Zamora; Robert H Squires
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-07       Impact factor: 2.839

10.  Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure.

Authors:  Filipe S Cardoso; Michelle Gottfried; Shannan Tujios; Jody C Olson; Constantine J Karvellas
Journal:  Hepatology       Date:  2017-12-26       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.